{"product_id":"skdiscovery-business-model-canvas","title":"SK Discovery Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDownload the complete Business Model Canvas: actionable strategy for investors and founders\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock SK Discovery’s strategic playbook with our full Business Model Canvas—detailing value propositions, key partners, revenue streams and cost drivers in one ready-to-use file. Perfect for investors, consultants, and founders who want actionable insights—download the complete canvas now to benchmark and build winning strategies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic alliances with SK group affiliates\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCollaborate closely with SK Chemicals, SK Gas and other SK Group affiliates—over 70 affiliates in 2024—aligning portfolio strategy and sharing R\u0026amp;D, supply-chain and market capabilities. Joint planning and co-investment improve capital efficiency and speed market entry, with group JV models historically cutting combined time-to-market and duplicative capex. Shared services reduce overhead and strengthen governance, while cross-selling and integrated solutions unlock revenue synergies across chemicals, energy and mobility.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eR\u0026amp;D and biotech co-development partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePartner with universities, research institutes, and biotech startups to co-develop advanced therapeutics and platform technologies, sharing costs and expertise across discovery and translational stages. Shared IP frameworks and milestone-based agreements de-risk early-stage science and preserve upside for follow-on investment. Access to external pipelines expands optionality for portfolio prioritization and out-licensing. Clinical and regulatory collaboration with partners shortens time-to-market through joint trials and regulatory filings.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGreen materials and sustainability ecosystem\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eForm alliances with renewable feedstock suppliers, recyclers and circular-economy platforms to secure feedstock for bioplastics and eco-materials; global bioplastics production capacity reached about 3.8 million tonnes in 2024, underscoring supply growth. Joint certification and lifecycle assessments (ISO\/EN standards) strengthen ESG credentials and reduce Scope 3 risk, while co-marketing with downstream users accelerates commercial adoption and market penetration.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFinancial and capital market partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSK Discovery partners with banks, PE\/VC funds and institutional investors for co-investments and financing, leveraging 2024 market liquidity where private equity dry powder exceeds over $1 trillion to scale transaction capacity. Syndication enables larger deals and risk sharing across participants, while debt and hybrid instruments optimize cost of capital and preserve equity upside. Research coverage and active investor relations amplify valuation and access to follow-on capital.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCo-investments with PE\/VC and banks for scale\u003c\/li\u003e\n\u003cli\u003eSyndication for risk sharing and larger ticket sizes\u003c\/li\u003e\n\u003cli\u003eDebt\/hybrid instruments to lower WACC\u003c\/li\u003e\n\u003cli\u003eResearch \u0026amp; IR to boost valuation and liquidity\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory, compliance, and certification bodies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eEngage agencies for chemical safety, pharma approvals, and environmental compliance to align dossiers and testing early; FDA review targets are 6 months for priority and 10 months for standard PDUFA reviews, reducing approval risk. Active participation in ISO\/standards committees helps shape favorable norms, while CE marking, FDA clearance, and ISO certifications expand market access and enhance customer trust.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRegulatory engagement: align dossiers early\u003c\/li\u003e\n\u003cli\u003ePDUFA timelines: 6m priority \/ 10m standard\u003c\/li\u003e\n\u003cli\u003eStandards participation: influence industry norms\u003c\/li\u003e\n\u003cli\u003eCertifications: CE, FDA, ISO = trust + access\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCollaborate with 70+ affiliates, universities and CROs to speed bioplastics and de-risk pipelines\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCollaborate with 70+ SK Group affiliates in 2024 to share R\u0026amp;D, supply-chain and co-investment, reducing time-to-market and duplicative capex. Partner with universities, startups and CROs to de-risk pipelines via milestone IP deals and joint trials (PDUFA 6m priority \/ 10m standard). Secure renewable feedstocks (bioplastics capacity ~3.8Mt in 2024) and finance via PE\/VC\/banks (dry powder \u0026gt;$1T in 2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner Type\u003c\/th\u003e\n\u003cth\u003eRole\u003c\/th\u003e\n\u003cth\u003e2024 Metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSK Affiliates\u003c\/td\u003e\n\u003ctd\u003eCo-invest\/R\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003e70+ affiliates\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eResearch\u003c\/td\u003e\n\u003ctd\u003eCo-development\u003c\/td\u003e\n\u003ctd\u003eJoint trials\/IP\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFeedstock\u003c\/td\u003e\n\u003ctd\u003eSupply \u0026amp; certification\u003c\/td\u003e\n\u003ctd\u003e3.8Mt bioplastics\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFinance\u003c\/td\u003e\n\u003ctd\u003eSyndication\u003c\/td\u003e\n\u003ctd\u003e$1T+ dry powder\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, pre-written Business Model Canvas for SK Discovery that maps customer segments, value propositions, channels, revenue streams and key resources across the 9 BMC blocks, reflecting real-world operations and strategic plans. It includes competitive-advantage analysis, linked SWOT insights and investor-ready presentation styling to support decision-making and funding discussions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level view of SK Discovery’s business model with editable cells to quickly pinpoint value drivers, revenue streams, and R\u0026amp;D pain points for faster strategic decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePortfolio strategy and capital allocation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSK Discovery assesses industry attractiveness across chemicals, life sciences, and materials, allocating capital to segments where margins and growth outlook justify investment, targeting hurdle rates in the 10–15% range and defining value-creation plans for each asset. Holdings are rebalanced quarterly against performance and risk limits, with buy, build, and divest decisions executed decisively to optimize ROIC. Portfolio shifts align with sector momentum and cash-return targets to support strategic growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSynergy realization across subsidiaries\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAlign shared R\u0026amp;D pipelines, consolidated procurement and unified go-to-market plans to capture cross-subsidiary product and channel opportunities.\u003c\/p\u003e\n\u003cp\u003eIntegrate supply chains and shared services for IT, HR and compliance to reduce duplicate overhead and compress lead times.\u003c\/p\u003e\n\u003cp\u003eDeploy monthly synergy KPIs (cost savings, time-to-market, supplier consolidation) tied to incentives; a 2024 industry study warns roughly 70% of announced synergies fail to fully materialize, so rigorous tracking is essential.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVenture building and incubation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSpin out and nurture green and biotech ventures through seed funding (typical rounds USD 0.5–5M), hands-on governance and corporate market access, de-risking technologies via pilots and strategic partnerships, and scale winners through targeted M\u0026amp;A to capture industrial synergies and accelerate commercialization.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology scouting and IP management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eTechnology scouting and IP management scans global materials and biotech breakthroughs, feeding a pipeline informed by 2024 deal flow (global biotech VC ~24 billion USD) and prioritized via technical and commercial diligence to de‑risk targets.\u003c\/p\u003e\n\u003cp\u003eTeams structure licensing and joint‑development agreements to capture royalties and milestones while building and defending core IP portfolios for long‑term value creation.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003escan: global deal flow 2024 ~24B USD\u003c\/li\u003e\n\u003cli\u003ediligence: technical + commercial\u003c\/li\u003e\n\u003cli\u003elegal: licensing, JDA, IP defense\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRisk, ESG, and regulatory management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMonitor commodity, clinical, and regulatory risks—Brent crude averaged about $86\/bbl in 2024—while tracking industry clinical success rates near 12% to price pipelines and hedges. Embed ESG targets across the portfolio and align with EU CSRD phased application starting 2024 to meet reporting timelines. Ensure compliance with chemical and pharma standards and report transparently to investors and regulators.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCommodity volatility: Brent ~$86\/bbl (2024)\u003c\/li\u003e\n\u003cli\u003eClinical success rate: ~12%\u003c\/li\u003e\n\u003cli\u003eRegulatory: EU CSRD phased from 2024\u003c\/li\u003e\n\u003cli\u003eActions: ESG targets, compliance, transparent reporting\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTargeting \u003cstrong\u003e10–15%\u003c\/strong\u003e IRR; quarterly buy\/build\/divest; seeds \u003cstrong\u003e0.5–5M USD\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSK Discovery targets 10–15% hurdle IRR, reallocates quarterly via buy\/build\/divest, tracks monthly synergy KPIs as ~70% announced synergies underdeliver, and seeds green\/biotech rounds of USD 0.5–5M while scanning global biotech VC flow ~24B USD (2024); it hedges commodity risk (Brent ~86 USD\/bbl) and prices pipelines to ~12% clinical success while meeting EU CSRD 2024 timelines.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 Value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHurdle IRR\u003c\/td\u003e\n\u003ctd\u003e10–15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSynergy realization risk\u003c\/td\u003e\n\u003ctd\u003e~70% fail to fully materialize\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiotech VC flow\u003c\/td\u003e\n\u003ctd\u003e~24B USD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSeed rounds\u003c\/td\u003e\n\u003ctd\u003e0.5–5M USD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBrent\u003c\/td\u003e\n\u003ctd\u003e~86 USD\/bbl\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinical success rate\u003c\/td\u003e\n\u003ctd\u003e~12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the actual SK Discovery Business Model Canvas you'll receive after purchase. It's not a mockup—this preview is a direct excerpt of the final file. After ordering you'll get the complete, editable document formatted identically for immediate use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":55675016577401,"sku":"skdiscovery-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/skdiscovery-business-model-canvas.png?v=1755800039","url":"https:\/\/portersfiveforce.com\/products\/skdiscovery-business-model-canvas","provider":"Porter's Five Forces","version":"1.0","type":"link"}